Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus
暂无分享,去创建一个
[1] Patricia L. Blount,et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. , 1993, Gastroenterology.
[2] J. Peters,et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. , 1994, The Journal of thoracic and cardiovascular surgery.
[3] M. Johnston,et al. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. , 1996, The American journal of gastroenterology.
[5] R. Sampliner,et al. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. , 1996, Gastrointestinal endoscopy.
[6] D. Castell,et al. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice Parameters Committee of the American College of Gastroenterology. , 1995, Archives of internal medicine.
[7] T. Hennessy,et al. Proliferating cell nuclear antigen in the assessment of Barrett's mucosa , 1994, The British journal of surgery.
[8] F. Ellis,et al. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. , 1978, American journal of clinical pathology.
[9] G. Lapertosa,et al. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. , 1996, Gastrointestinal endoscopy.
[10] P. Stevens,et al. Hypertensive emergency and ventricular tachycardia after endoscopic epinephrine injection of a Mallory-Weiss tear. , 1994, Gastrointestinal endoscopy.
[11] R. Sampliner,et al. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. , 1997, The American journal of gastroenterology.
[12] A. Cameron,et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. , 1995, Gastroenterology.
[13] D. Katzka,et al. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. , 1994, The American journal of gastroenterology.
[14] A R Zinsmeister,et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. , 1993, Gastroenterology.
[15] Carissa A. Sanchez,et al. p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. , 1994, Gastroenterology.
[16] N. Walker,et al. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. , 1991, Gut.
[17] J. Jankowski,et al. Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: Biological and clinical variables , 1995, International journal of cancer.
[18] S. Spechler,et al. Scanning electron microscopy of Barrett's epithelium and its correlation with light microscopy and mucin stains. , 1986, Gastroenterology.
[19] R. Heitmiller,et al. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. , 1996, Annals of surgery.
[20] J. Mayberry,et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus , 1988, The British journal of surgery.
[21] R. Sampliner,et al. Ornithine decarboxylase activity in Barrett's esophagus: a potential marker for dysplasia. , 1988, Gastroenterology.
[22] D J Ballard,et al. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. , 1990, Gastroenterology.
[23] P. Dítě,et al. [Barrett's esophagus]. , 2000, Bratislavske lekarske listy.
[24] J. Richter,et al. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. , 1996, Gastroenterology.
[25] D. Hopwood,et al. Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma. , 1992, Scandinavian journal of gastroenterology.
[26] J. Pignon,et al. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases. , 1995, The American journal of surgical pathology.
[27] D. Skinner,et al. Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. , 1983, Archives of surgery.
[28] W. Hop,et al. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. , 1995, Gut.
[29] G Whelan,et al. Prevalence of columnar-lined (Barrett's) esophagus. , 1991, Gastroenterology.
[30] C. Winters,et al. Esophageal acid sensitivity in Barrett's esophagus. , 1987, Journal of clinical gastroenterology.
[31] M. Helfand,et al. Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. , 1997, The American journal of gastroenterology.
[32] R. Goyal,et al. Prevalence of metaplasia at the gastro-oesophageal junction , 1994, The Lancet.
[33] J. Fraumeni,et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.
[34] A. Bhattacharyya,et al. Intestinal metaplasia of the gastric cardia. , 1997, The American journal of gastroenterology.
[35] T. Demeester,et al. Functional foregut abnormalities in Barrett's esophagus. , 1993, The Journal of thoracic and cardiovascular surgery.
[36] J. Rosenberg,et al. Analysis of adenocarcinoma in barrett's esophagus utilizing a staging system , 1985, Cancer.
[37] J. Richardson,et al. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. , 1996, Annals of surgery.
[38] G Van Belle,et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.
[39] B. Reid,et al. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. , 1987, Gastroenterology.
[40] R. Hunt,et al. A study to examine agreement between endoscopy and histology for the diagnosis of columnar lined (Barrett's) esophagus. , 1989, Gastrointestinal endoscopy.
[41] J. Freston,et al. Critical issues in the management of gastroesophageal reflux disease. , 1995, European journal of gastroenterology & hepatology.
[42] D. Lane,et al. Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization. , 1992, Gastroenterology.
[43] G. Meyer,et al. Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease , 1995 .
[44] J. Peters,et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? , 1994, Archives of surgery.
[45] R. Sampliner,et al. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. , 1989, Gastroenterology.
[46] J. Boitnott,et al. The spectrum of carcinoma arising in Barrett's esophagus: A clinicopathologic study of 26 patients , 1984, The American journal of surgical pathology.
[47] D. Grueneberg,et al. DNA content in Barrett's esophagus and esophageal malignancy. , 1987, The American journal of gastroenterology.
[48] C. Lightdale,et al. Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus. , 1994, Gastrointestinal endoscopy.
[49] R. Lebovitz,et al. p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. , 1993, Gastroenterology.
[50] B. Overholt,et al. Photodynamic therapy for Barrett's esophagus: clinical update. , 1996, The American journal of gastroenterology.
[51] R. R. Smith,et al. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. , 1988, Human pathology.
[52] C. Winters,et al. In vivo staining with toluidine blue as an adjunct to the endoscopic detection of Barrett's esophagus. , 1987, Gastrointestinal endoscopy.
[53] D. Ransohoff,et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.
[54] R. Sampliner,et al. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. , 1997, The American journal of gastroenterology.
[55] A. Bhattacharyya,et al. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. , 1997, The American journal of gastroenterology.
[56] D. Skinner,et al. Barrett's Esophagus: Comparison of Benign and Malignant Cases , 1983, Annals of surgery.
[57] P. Blount,et al. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. , 1992, Gastroenterology.
[58] R. Sandler,et al. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. , 1997, The American journal of gastroenterology.
[59] J. G. van den Tweel,et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.
[60] P. Blount,et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. , 1992, Gastroenterology.
[61] W. Macdonald,et al. Adenocarcinoma of the Esophagus and/or Gastric Cardia , 1987, Cancer.
[62] R. Cherian,et al. Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. , 1996, The American journal of gastroenterology.
[63] S. Spechler. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. , 1992, The New England journal of medicine.